Sanginita Research Development vs Total Revenue Analysis

SANGINITA

16.18 0.63 4.05%

Sanginita Chemicals financial indicator trend analysis is much more than just breaking down Sanginita Chemicals prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Sanginita Chemicals is a good investment. Please check the relationship between Sanginita Chemicals Research Development and its Total Revenue accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sanginita Chemicals Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

Research Development vs Total Revenue

Research Development vs Total Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Sanginita Chemicals Research Development account and Total Revenue. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Sanginita Chemicals' Research Development and Total Revenue is -0.15. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Total Revenue in the same time period over historical financial statements of Sanginita Chemicals Limited, assuming nothing else is changed. The correlation between historical values of Sanginita Chemicals' Research Development and Total Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Sanginita Chemicals Limited are associated (or correlated) with its Total Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Revenue has no effect on the direction of Research Development i.e., Sanginita Chemicals' Research Development and Total Revenue go up and down completely randomly.

Correlation Coefficient

-0.15

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Research Development

Total Revenue

Total revenue comprises all receipts Sanginita Chemicals generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Most indicators from Sanginita Chemicals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Sanginita Chemicals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sanginita Chemicals Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

The current Tax Provision is estimated to decrease to about 2.6 M. The current Selling General Administrative is estimated to decrease to about 1.2 M

	2021	2022	2023	2024 (projected)
Interest Expense	20.1M	25.0M	26.1M	21.8M
Depreciation And Amortization	5.8M	5.5M	7.4M	6.6M

Interest Expense Depreciation And Amortization

Sanginita Chemicals fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Net Receivables	Other Assets	Other Liab
Total Assets		0.87	-0.01	0.9	0.98	0.03	-0.33	0.87	0.93	0.5	-0.55	0.43	0.07	-0.55	0.43	0.45	0.9	-0.29	0.9	0.9	1.0	0.86	0.93	0.34	0.62	-0.91
Short Long Term Debt Total	0.87		-0.18	0.78	0.85	0.08	-0.2	1.0	0.85	0.24	-0.57	0.27	-0.24	-0.57	0.41	0.47	0.77	-0.29	0.75	0.78	0.88	0.98	0.77	0.21	0.49	-0.9
Other Current Liab	-0.01	-0.18		0.05	-0.05	0.24	0.0	-0.18	-0.07	0.29	0.16	0.16	0.4	0.16	0.31	0.19	0.06	0.12	-0.04	0.07	-0.03	-0.14	0.01	-0.15	0.31	0.12
Total Current Liabilities	0.9	0.78	0.05		0.79	0.22	-0.27	0.78	0.8	0.72	-0.47	0.49	-0.03	-0.47	0.55	0.49	0.84	-0.06	0.69	0.99	0.89	0.73	0.74	0.29	0.68	-0.76
Total Stockholder Equity	0.98	0.85	-0.05	0.79		-0.08	-0.31	0.85	0.91	0.34	-0.54	0.35	0.08	-0.54	0.32	0.35	0.85	-0.4	0.95	0.78	0.98	0.86	0.96	0.39	0.54	-0.92
Property Plant And Equipment Net	0.03	0.08	0.24	0.22	-0.08		0.08	0.08	0.05	0.27	-0.16	0.54	0.02	-0.16	0.76	0.34	0.25	0.35	-0.18	0.25	-0.02	0.04	-0.05	-0.4	0.48	0.02
Current Deferred Revenue	-0.33	-0.2	0.0	-0.27	-0.31	0.08		-0.2	-0.4	-0.45	0.03	-0.4	-0.49	0.03	-0.27	-0.53	-0.43	-0.25	-0.2	-0.34	-0.31	-0.12	-0.24	0.03	-0.48	0.27
Net Debt	0.87	1.0	-0.18	0.78	0.85	0.08	-0.2		0.86	0.23	-0.58	0.28	-0.24	-0.58	0.41	0.47	0.77	-0.29	0.75	0.78	0.88	0.98	0.77	0.21	0.49	-0.9
Retained Earnings	0.93	0.85	-0.07	0.8	0.91	0.05	-0.4	0.86		0.38	-0.73	0.49	0.11	-0.73	0.39	0.45	0.95	-0.17	0.74	0.81	0.91	0.83	0.77	0.06	0.6	-0.94
Accounts Payable	0.5	0.24	0.29	0.72	0.34	0.27	-0.45	0.23	0.38		-0.19	0.51	0.33	-0.19	0.61	0.6	0.54	0.35	0.27	0.73	0.47	0.16	0.34	0.18	0.75	-0.31
Cash	-0.55	-0.57	0.16	-0.47	-0.54	-0.16	0.03	-0.58	-0.73	-0.19		-0.36	-0.03	1.0	-0.31	-0.34	-0.67	-0.03	-0.35	-0.48	-0.54	-0.57	-0.37	0.16	-0.43	0.67
Non Current Assets Total	0.43	0.27	0.16	0.49	0.35	0.54	-0.4	0.28	0.49	0.51	-0.36		0.6	-0.36	0.49	0.47	0.65	0.28	0.21	0.53	0.35	0.2	0.28	-0.34	0.78	-0.34
Non Currrent Assets Other	0.07	-0.24	0.4	-0.03	0.08	0.02	-0.49	-0.24	0.11	0.33	-0.03	0.6		-0.03	0.01	0.34	0.25	0.23	0.05	0.04	0.02	-0.26	0.05	-0.32	0.4	0.03
Cash And Short Term Investments	-0.55	-0.57	0.16	-0.47	-0.54	-0.16	0.03	-0.58	-0.73	-0.19	1.0	-0.36	-0.03		-0.31	-0.34	-0.67	-0.03	-0.35	-0.48	-0.54	-0.57	-0.37	0.16	-0.43	0.67
Common Stock Shares Outstanding	0.43	0.41	0.31	0.55	0.32	0.76	-0.27	0.41	0.39	0.61	-0.31	0.49	0.01	-0.31		0.61	0.53	0.32	0.22	0.58	0.4	0.39	0.36	-0.01	0.8	-0.37
Non Current Liabilities Total	0.45	0.47	0.19	0.49	0.35	0.34	-0.53	0.47	0.45	0.6	-0.34	0.47	0.34	-0.34	0.61		0.57	0.21	0.22	0.6	0.43	0.35	0.29	-0.23	0.68	-0.4
Inventory	0.9	0.77	0.06	0.84	0.85	0.25	-0.43	0.77	0.95	0.54	-0.67	0.65	0.25	-0.67	0.53	0.57		-0.14	0.69	0.87	0.88	0.72	0.74	-0.03	0.72	-0.86
Other Current Assets	-0.29	-0.29	0.12	-0.06	-0.4	0.35	-0.25	-0.29	-0.17	0.35	-0.03	0.28	0.23	-0.03	0.32	0.21	-0.14		-0.52	-0.04	-0.33	-0.34	-0.45	-0.33	0.28	0.3
Other Stockholder Equity	0.9	0.75	-0.04	0.69	0.95	-0.18	-0.2	0.75	0.74	0.27	-0.35	0.21	0.05	-0.35	0.22	0.22	0.69	-0.52		0.66	0.92	0.79	0.99	0.58	0.42	-0.8
Total Liab	0.9	0.78	0.07	0.99	0.78	0.25	-0.34	0.78	0.81	0.73	-0.48	0.53	0.04	-0.48	0.58	0.6	0.87	-0.04	0.66		0.88	0.71	0.72	0.21	0.7	-0.75
Total Current Assets	1.0	0.88	-0.03	0.89	0.98	-0.02	-0.31	0.88	0.91	0.47	-0.54	0.35	0.02	-0.54	0.4	0.43	0.88	-0.33	0.92	0.88		0.87	0.94	0.39	0.57	-0.91
Short Term Debt	0.86	0.98	-0.14	0.73	0.86	0.04	-0.12	0.98	0.83	0.16	-0.57	0.2	-0.26	-0.57	0.39	0.35	0.72	-0.34	0.79	0.71	0.87		0.81	0.27	0.46	-0.92
Common Stock	0.93	0.77	0.01	0.74	0.96	-0.05	-0.24	0.77	0.77	0.34	-0.37	0.28	0.05	-0.37	0.36	0.29	0.74	-0.45	0.99	0.72	0.94	0.81		0.54	0.5	-0.81
Net Receivables	0.34	0.21	-0.15	0.29	0.39	-0.4	0.03	0.21	0.06	0.18	0.16	-0.34	-0.32	0.16	-0.01	-0.23	-0.03	-0.33	0.58	0.21	0.39	0.27	0.54		-0.01	-0.16
Other Assets	0.62	0.49	0.31	0.68	0.54	0.48	-0.48	0.49	0.6	0.75	-0.43	0.78	0.4	-0.43	0.8	0.68	0.72	0.28	0.42	0.7	0.57	0.46	0.5	-0.01		-0.56
Other Liab	-0.91	-0.9	0.12	-0.76	-0.92	0.02	0.27	-0.9	-0.94	-0.31	0.67	-0.34	0.03	0.67	-0.37	-0.4	-0.86	0.3	-0.8	-0.75	-0.91	-0.92	-0.81	-0.16	-0.56

Click cells to compare fundamentals

Sanginita Chemicals Account Relationship Matchups

Sanginita Chemicals fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	783.8M	701.2M	792.0M	795.0M	859.3M	681.0M
Short Long Term Debt Total	349.4M	289.5M	345.1M	285.8M	328.7M	305.7M
Other Current Liab	(10.3M)	(1.8M)	(160K)	7.6M	11.4M	11.9M
Total Current Liabilities	394.7M	305.4M	358.9M	372.5M	422.5M	358.2M
Total Stockholder Equity	386.1M	393.7M	397.2M	401.4M	407.9M	309.4M
Property Plant And Equipment Net	38.7M	35.6M	36.6M	40.2M	72.0M	47.7M
Current Deferred Revenue	16.4M	8.6M	6.9M	1.3M	6.5M	9.3M
Net Debt	349.2M	289.4M	345.0M	285.5M	328.5M	304.9M
Retained Earnings	150.3M	157.9M	161.4M	165.5M	173.2M	111.4M
Accounts Payable	30.2M	8.2M	41.5M	97.2M	108.2M	113.6M
Cash	264K	84K	149K	272K	205K	194.8K
Non Current Assets Total	46.5M	42.9M	43.4M	92.0M	78.6M	55.2M
Non Currrent Assets Other	(39.2M)	2.3M	2.1M	47.4M	2.4M	1.8M
Cash And Short Term Investments	264K	84K	149K	272K	205K	194.8K
Liabilities And Stockholders Equity	783.8M	701.2M	792.0M	795.0M	859.3M	681.0M
Non Current Liabilities Total	3.0M	2.1M	35.9M	21.1M	28.8M	30.3M
Inventory	203.8M	218.8M	238.9M	269.2M	299.5M	194.1M
Other Current Assets	12.7M	14.3M	8.2M	178.7M	216.9M	227.7M
Total Liab	397.7M	307.5M	394.8M	393.6M	451.4M	371.5M
Total Current Assets	737.2M	658.4M	748.6M	703.0M	780.7M	625.8M
Short Term Debt	319.0M	287.7M	309.6M	263.9M	300.8M	290.7M
Net Receivables	391.7M	291.9M	251.0M	254.9M	271.5M	337.1M
Other Assets	7.4M	7.2M	6.8M	47.4M	54.5M	57.2M
Other Liab	368K	306K	345K	465K	418.5K	435.4K
Net Tangible Assets	385.6M	393.7M	397.2M	401.4M	461.6M	369.5M
Long Term Debt	2.6M	1.8M	35.6M	20.7M	27.8M	29.2M
Long Term Debt Total	2.6M	1.8M	35.6M	20.7M	23.7M	24.9M
Property Plant Equipment	38.7M	35.6M	36.6M	40.2M	46.2M	41.1M
Short Long Term Debt	346.9M	287.7M	309.6M	265.2M	300.8M	317.2M
Cash And Equivalents	264K	84K	149K	272K	244.8K	430.8K
Net Invested Capital	735.5M	683.2M	742.3M	687.2M	736.6M	755.4M
Net Working Capital	342.5M	353.0M	389.7M	330.5M	358.2M	371.7M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

TITAN	Titan Company Limited
U	Unity Software
PAYC	Paycom Soft

Other Information on Investing in Sanginita Stock

Balance Sheet is a snapshot of the financial position of Sanginita Chemicals at a specified time, usually calculated after every quarter, six months, or one year. Sanginita Chemicals Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Sanginita Chemicals and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Sanginita currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Sanginita Research Development vs Total Revenue Analysis

Research Development vs Total Revenue

Research Development vs Total Revenue Correlation Analysis

Correlation Coefficient

Research Development

Total Revenue

Sanginita Chemicals fundamental ratios Correlations

Sanginita Chemicals Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Sanginita Chemicals fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in Sanginita Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Net Debt	+ 1.0	Short Long Term Debt Total
Cash And Short Term Investments	+ 1.0	Cash
Total Liab	+ 0.99	Total Current Liabilities
Common Stock	+ 0.99	Other Stockholder Equity
Total Stockholder Equity	+ 0.98	Total Assets

Other Liab	- 0.94	Retained Earnings
Other Liab	- 0.92	Short Term Debt
Other Liab	- 0.92	Total Stockholder Equity
Other Liab	- 0.91	Total Current Assets
Other Liab	- 0.91	Total Assets
Other Liab	- 0.9	Net Debt